BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chakraborty S, Chopra P, Ambi SV, Dastidar SG, Ray A. Emerging therapeutic interventions for idiopathic pulmonary fibrosis. Expert Opin Investig Drugs 2014;23:893-910. [PMID: 24766571 DOI: 10.1517/13543784.2014.913569] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Shou J, Cao J, Zhang S, Sun R, Zhao M, Chen K, Su SB, Yang J, Yang T. SIS3, a specific inhibitor of smad3, attenuates bleomycin-induced pulmonary fibrosis in mice. Biochemical and Biophysical Research Communications 2018;503:757-62. [DOI: 10.1016/j.bbrc.2018.06.072] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
2 Vasse GF, Kühn PT, Zhou Q, Bhusari SA, Reker-smit C, Melgert BN, van Rijn P. Collagen morphology influences macrophage shape and marker expression in vitro. Journal of Immunology and Regenerative Medicine 2018;1:13-20. [DOI: 10.1016/j.regen.2018.01.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
3 Coentro JQ, Pugliese E, Hanley G, Raghunath M, Zeugolis DI. Current and upcoming therapies to modulate skin scarring and fibrosis. Advanced Drug Delivery Reviews 2019;146:37-59. [DOI: 10.1016/j.addr.2018.08.009] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 13.3] [Reference Citation Analysis]
4 Wang Y, Hu S, Shen L, Liu S, Wan L, Yang S, Hou M, Tian X, Zhang H, Xu KF. Dynamic Observation of Autophagy and Transcriptome Profiles in a Mouse Model of Bleomycin-Induced Pulmonary Fibrosis. Front Mol Biosci 2021;8:664913. [PMID: 34395518 DOI: 10.3389/fmolb.2021.664913] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Manresa MC, Godson C, Taylor CT. Hypoxia-sensitive pathways in inflammation-driven fibrosis. Am J Physiol Regul Integr Comp Physiol 2014;307:R1369-80. [PMID: 25298511 DOI: 10.1152/ajpregu.00349.2014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
6 Agarwal SK. Integrins and cadherins as therapeutic targets in fibrosis. Front Pharmacol 2014;5:131. [PMID: 24917820 DOI: 10.3389/fphar.2014.00131] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
7 Liu Y, Nepali K, Liou J. Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets. J Med Chem 2017;60:527-53. [DOI: 10.1021/acs.jmedchem.6b00935] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
8 Lin S, Jin J, Liu Y, Tian H, Zhang Y, Fu R, Zhang J, Wang M, Du T, Ji M, Wu D, Zhang K, Sheng L, Li Y, Chen X, Xu H. Discovery of 4-Methylquinazoline Based PI3K Inhibitors for the Potential Treatment of Idiopathic Pulmonary Fibrosis. J Med Chem 2019;62:8873-9. [DOI: 10.1021/acs.jmedchem.9b00969] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ballester B, Milara J, Cortijo J. Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets. Int J Mol Sci 2019;20:E593. [PMID: 30704051 DOI: 10.3390/ijms20030593] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 18.0] [Reference Citation Analysis]
10 Fois AG, Paliogiannis P, Sotgia S, Mangoni AA, Zinellu E, Pirina P, Carru C, Zinellu A. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review. Respir Res 2018;19:51. [PMID: 29587761 DOI: 10.1186/s12931-018-0754-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
11 Hu J, Shang D, Xu X, He X, Ni X, Zhang M, Wang Z, Qiu C, Deng S, Lu H, Zhu X, Huang W, Wen Y. Effect of grapefruit juice and food on the pharmacokinetics of pirfenidone in healthy Chinese volunteers: a diet-drug interaction study. Xenobiotica 2016;46:516-21. [PMID: 26407124 DOI: 10.3109/00498254.2015.1089365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
12 Lin R, Zhang Z, Cao S, Yang W, Zuo Y, Yang X, Zhang J, Xu J, Li J, Wang X. The development of HEC-866 and its analogues for the treatment of idiopathic pulmonary fibrosis. RSC Med Chem 2021;12:1222-31. [PMID: 34355186 DOI: 10.1039/d1md00023c] [Reference Citation Analysis]
13 Campiani G, Cavella C, Osko JD, Brindisi M, Relitti N, Brogi S, Saraswati AP, Federico S, Chemi G, Maramai S, Carullo G, Jaeger B, Carleo A, Benedetti R, Sarno F, Lamponi S, Rottoli P, Bargagli E, Bertucci C, Tedesco D, Herp D, Senger J, Ruberti G, Saccoccia F, Saponara S, Gorelli B, Valoti M, Kennedy B, Sundaramurthi H, Butini S, Jung M, Roach KM, Altucci L, Bradding P, Christianson DW, Gemma S, Prasse A. Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors. J Med Chem 2021;64:9960-88. [PMID: 34251197 DOI: 10.1021/acs.jmedchem.1c00184] [Reference Citation Analysis]
14 Lukey PT, Coello C, Gunn R, Parker C, Wilson FJ, Saleem A, Garman N, Costa M, Kendrick S, Onega M, Kang'ombe AR, Listanco A, Davies J, Ramada-Magalhaes J, Moz S, Fahy WA, Maher TM, Jenkins G, Passchier J, Marshall RP. Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study). Eur J Nucl Med Mol Imaging 2020;47:967-79. [PMID: 31814068 DOI: 10.1007/s00259-019-04586-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
15 Tian SL, Yang Y, Liu XL, Xu QB. Emodin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Anti-Inflammatory and Anti-Oxidative Activities in Rats. Med Sci Monit 2018;24:1-10. [PMID: 29290631 DOI: 10.12659/msm.905496] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
16 Forte G, Bocca B, Pisano A, Collu C, Farace C, Sabalic A, Senofonte M, Fois AG, Mazzarello VL, Pirina P, Madeddu R. The levels of trace elements in sputum as biomarkers for idiopathic pulmonary fibrosis. Chemosphere 2021;271:129514. [PMID: 33434828 DOI: 10.1016/j.chemosphere.2020.129514] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Pini A, Verta R, Grange C, Gurrieri M, Rosa AC. Histamine and diabetic nephropathy: an up-to-date overview. Clin Sci (Lond) 2019;133:41-54. [PMID: 30606813 DOI: 10.1042/CS20180839] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]